Chester County News and Community Website
WASHINGTON, D.C. — The Food and Drug Administration (FDA) has issued a public health alert advising consumers to discard and avoid purchasing El Servidor brand ground cinnamon. This product, distributed …
FDA Issues Health Alert for Lead-Contaminated Cinnamon Read More
WASHINGTON, D.C. — The Food and Drug Administration (FDA) has issued a safety alert advising restaurants and retailers not to serve or sell, and consumers not to eat, certain oysters …
FDA Warns Against Potentially Contaminated Oysters from Maine Read More
JOHNSTOWN, PA — On Wednesday, Pennsylvania Department of Drug and Alcohol Programs (DDAP) Secretary Dr. Latika Davis-Jones joined local leaders and experts in Johnstown for a roundtable discussion on the opioid …
Pennsylvania Officials Address Opioid Crisis in Johnstown Read More
PHILADELPHIA, PA — New research highlights a critical connection between the size of initial opioid prescriptions and prolonged use following hand and upper extremity surgeries. This underscores the need for …
Study Reveals Link Between Initial Opioid Prescription Size and Prolonged Use Read More
WASHINGTON, D.C. — The Food and Drug Administration (FDA) this week approved Femlyv, the first orally disintegrating tablet for preventing pregnancy. This new form of birth control offers an alternative …
FDA Approves First Dissolvable Birth Control Pill Read More
WASHINGTON, D.C. — The Food and Drug Administration (FDA) has updated its guidance regarding diagnostic tests for Highly Pathogenic Avian Influenza (HPAI). The new information can be found on the …
FDA Updates Guidance on Avian Influenza Diagnostic Tests Read More
WASHINGTON, D.C. — In a recent blog post, FDA Commissioner Dr. Robert M. Califf delved into the troubling decline in men’s health across the United States. This piece, titled “Men’s …
FDA Commissioner Highlights Alarming Decline in Men’s Health Read More
WASHINGTON, D.C. — The Food and Drug Administration announced plans to create a Rare Disease Innovation Hub to accelerate the development of treatments for rare diseases. This initiative, detailed in …
FDA Launches Rare Disease Innovation Hub to Boost Treatment Development Read More
MALVERN, PA — Ocugen, Inc. (NASDAQ: OCGN) this week announced the completion of dosing in the third cohort of its Phase 1/2 ArMaDa clinical trial for OCU410, a novel gene …
Ocugen Completes Dosing in Phase 1/2 Trial for Gene Therapy to Treat Geographic Atrophy Read More
WASHINGTON, D.C. — The U.S. Food and Drug Administration (FDA) recently published a critical piece by Commissioner Robert M. Califf, M.D., titled “From Awareness to Action: Tackling the Rising Burden …
FDA Commissioner Highlights Rising Burden of Chronic Diseases Read More